Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.16% is 38% above its 5-year average of 7.35%, near the high end of its 5-year range (0.00%–10.89%).
As of the fiscal period ended Wednesday, December 31, 2025. 43.10% above its 12-month average of 7.10%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
10.16%
RETURN ON ASSETS (ROA) AVG TTM
7.10%
RETURN ON ASSETS (ROA) AVG 3Y
8.43%
RETURN ON ASSETS (ROA) AVG 5Y
7.35%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+43.10%
CURRENT VS 3Y AVG
+20.49%
CURRENT VS 5Y AVG
+38.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+106.92%
vs the sector median at left
Solventum Corporation
Market Cap
$15.17B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$16.15B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$14.14B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$16.97B
Return on Assets (ROA)
5.92%
TTM Avg
7.45%
3Y Avg
8.56%
5Y Avg
11.79%
Market Cap
$12.89B
Return on Assets (ROA)
6.81%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$12.67B
Return on Assets (ROA)
-5.53%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$12.39B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$11.72B
Return on Assets (ROA)
10.14%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.17B | 10.16% | 7.10% | 8.43% | 7.35% |
| DaVita Inc. (DVA)vs › | $15.47B | 4.47% | 4.84% | 4.27% | 4.56% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.15B | 23.89% | 21.05% | 19.32% | 16.45% |
| The Cooper Companies, Inc. (COO)vs › | $14.14B | 1.89% | 3.10% | 3.02% | 7.71% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Align Technology, Inc. (ALGN)vs › | $12.89B | 6.81% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX)vs › | $12.67B | -5.53% | -3.64% | -1.62% | 0.47% |
| Revvity, Inc. (RVTY)vs › | $12.39B | 2.01% | 2.19% | 1.89% | 3.83% |
| Insulet Corp. (PODD)vs › | $11.72B | 10.14% | 10.65% | 7.37% | 5.11% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.63B | 3.35% | 3.64% | 3.29% | 2.38% |
ROA
10.2%
ROE
28.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 10.89% |
| 2024-12-31 | 3.31% |
| 2023-12-31 | 9.65% |
| 2022-12-31 | 9.88% |
| 2021-12-31 | 10.37% |
| 2020-12-31 | 0.00% |
